ATPase H+ transporting accessory protein 1
| UniProt | Protein Name |
|---|---|
| A0A384MQW4 |
|
| Q15904 |
|
| GO Term | Evidence Code | PMID |
|---|---|---|
| intracellular iron ion homeostasis |
|
|
| vacuolar acidification |
|
|
| lysosomal lumen acidification |
|
|
| obsolete regulation of cellular pH |
|
|
| osteoclast development |
|
| GO Term | Evidence Code | PMID |
|---|---|---|
| Golgi membrane |
|
|
| lysosomal membrane |
|
|
| lysosomal membrane |
|
|
| endoplasmic reticulum membrane |
|
|
| endoplasmic reticulum membrane |
|
| GO Term | Evidence Code | PMID |
|---|---|---|
| ATPase activator activity |
|
|
| protein binding |
|
|
| small GTPase binding |
|
|
| small GTPase binding |
|
|
| molecular function activator activity |
|
| InterPro |
|---|
| V-type proton ATPase subunit S1, luminal domain |
| V-type proton ATPase subunit S1/VOA1, transmembrane domain |
| V0 complex accessory subunit Ac45 |
Tissue with high expression from Human Protein Atlas. Tissues that are highly expressed are highlighted.
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:0112002 | immunodeficiency 47 |
| HPO ID | HPO Term |
|---|---|
| HP:0000348 | High forehead |
| HP:0000407 | Sensorineural hearing impairment |
| HP:0000540 | Hypermetropia |
| HP:0000601 | Hypotelorism |
| HP:0000973 | Cutis laxa |
| HP:0001250 | Seizure |
| HP:0001252 | Hypotonia |
| HP:0001256 | Intellectual disability, mild |
| HP:0001263 | Global developmental delay |
| HP:0001382 | Joint hypermobility |
| Disease ID | Disease Name |
|---|---|
| OMIM:300972 |
|
| Species | Gene ID | Alliance of Genome Resources |
|---|---|---|
| 54411 | MGI:109629 | |
| 83615 | RGD:620423 | |
| 177103 | WB:WBGene00021952 | |
| 35944 | FB:FBgn0262515 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026